03.02.15
Pierre Fabre, the French dermocosmetics company, has renewed its partnership with Abbott Healthcare. The move ensures that Pierre Fabre's line of skin care products will continue to be available in one of the largest consumer product companies in the world, according to company executives. The agreement includes brands such as Avene, Ducray and A-Derma.
"Pierre Fabre's background as a pharmaceutical company specializing in dermatology in addition wiith its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbot," explained M. Eric Ducouranau, chairman, Pierre Fabre Dermo-Cosmetics. "In order to fulfill the highest expectations of sensitive or fragile skins, clinical and cosnumers tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin."
Abbott is a global healthcare company with activities in more than 150 countries. It employs 77,000, including more than 14,000 in India.
"The dermo-cosmetic market in India is fairly new, but has a lot of potential," explained M. Pierre Behnam, country head, Indian operation. "The dermo-cosmetic market in India is fairly new, but has a lot of potential. The current market size can be pegged at around 100 million euros within five years. We have plans to launch six new types of products per year and are therefore confident that our premium brands will be instrumental to convert this potential."
"Pierre Fabre's background as a pharmaceutical company specializing in dermatology in addition wiith its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbot," explained M. Eric Ducouranau, chairman, Pierre Fabre Dermo-Cosmetics. "In order to fulfill the highest expectations of sensitive or fragile skins, clinical and cosnumers tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin."
Abbott is a global healthcare company with activities in more than 150 countries. It employs 77,000, including more than 14,000 in India.
"The dermo-cosmetic market in India is fairly new, but has a lot of potential," explained M. Pierre Behnam, country head, Indian operation. "The dermo-cosmetic market in India is fairly new, but has a lot of potential. The current market size can be pegged at around 100 million euros within five years. We have plans to launch six new types of products per year and are therefore confident that our premium brands will be instrumental to convert this potential."
"Pierre Fabre's background as a pharmaceutical company specialising in dermatology in addition with its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbott. In order to fulfil the highest expectations of sensitive or fragile skins, clinical and consumer tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin," added M. Eric Ducournau, Chairman, Pierre Fabre Dermo-Cosmetics. - See more at: http://www.wellnessindia.com/article/health-and-beauty/skin-and-anti-aging/Pierre-Fabre-dermo-cosmetics-Abbott-Healthcare-strengthen-partnership-to-re-define-care-for-Indian-skin.a246/#sthash.UFoZ6ae4.dpuf